): Abnormal chromosome number (aneuploidy) has been observed in many human tumors but the mechanism by which cells become aneuploid is not known. Defective spindle function during anaphase is one possible mechanism. The broad objective of the research outlined in this proposal is to identify genes important during anaphase and use the combination of yeast genetics, molecular biology, biochemistry, in vivo and in vitro studies to investigate the mechanism of spindle elongation in S. cervisiae during anaphase B. Investigating this step in mitosis should yield useful information to help explain aspects of the pathophysiology of human cancers as well as potentially provide new targets for anticancer treatment. One anaphase specific gene, ASE1, has recently been identified in S. cerevisiae. The location of ASE1 at the mitotic midzone in late anaphase/telophase suggests it may be important for spindle elongation. The research of the applicant will focus on determining the microtubule binding properties of ASE1, identifying other genes required for anaphase using a genetic screen for genes that have overlapping function with ASE1, and developing an in vitro system in which spindle elongation is reconstituted, ultimately with purified components. Eventually, analogous human genes will be identified and their role in malignant transformation studied. The applicant's prior training includes both a rigorous basic science background as well as extensive clinical experience. This project was selected because it allows her to combine her interests in microtubule-based activities with her clinical interests in oncology. In addition, she will gain expertise in the powerful techniques of yeast genetics and molecular biology. This training will provide an ideal environment for her to develop into an independent investigator with the long-term goal of continued research focused on understanding the pathophysiology of human cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Program Officer
Myrick, Dorkina C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Roberts, Penelope S; Chung, Joon; Jozwiak, Sergiusz et al. (2002) SNP identification, haplotype analysis, and parental origin of mutations in TSC2. Hum Genet 111:96-101
Franz, D N; Brody, A; Meyer, C et al. (2001) Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 164:661-8
Dabora, S L; Jozwiak, S; Franz, D N et al. (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68:64-80
Roberts, P S; Jozwiak, S; Kwiatkowski, D J et al. (2001) Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene. J Biochem Biophys Methods 47:33-7
Dabora, S L; Nieto, A A; Franz, D et al. (2000) Characterisation of six large deletions in TSC2 identified using long range PCR suggests diverse mechanisms including Alu mediated recombination. J Med Genet 37:877-83
Choy, Y S; Dabora, S L; Hall, F et al. (1999) Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet 63:383-91
Dabora, S L; Sigalas, I; Hall, F et al. (1998) Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE. Ann Hum Genet 62:491-504